Dermata Historical Balance Sheet

DRMAW Stock

USD 0.02 0.01 31.43%

Trend analysis of Dermata Therapeutics Warrant balance sheet accounts such as Other Current Liabilities of 730.3 K or Total Current Liabilities of 1.5 M provides information on Dermata Therapeutics' total assets, liabilities, and equity, which is the actual value of Dermata Therapeutics to its prevalent stockholders. By breaking down trends over time using Dermata Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Dermata Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dermata Therapeutics is a good buy for the upcoming year.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Dermata Stock please use our How to Invest in Dermata Therapeutics guide.

About Dermata Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Dermata Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Dermata Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Dermata Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Dermata currently owns. An asset can also be divided into two categories, current and non-current.

Dermata Therapeutics Balance Sheet Chart

At this time, Dermata Therapeutics' Total Current Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 444.4 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 1.5 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Total Assets

Total assets refers to the total amount of Dermata Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dermata Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Dermata Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Dermata Therapeutics Warrant are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Dermata Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Dermata Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Dermata Stock please use our How to Invest in Dermata Therapeutics guide.At this time, Dermata Therapeutics' Total Current Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 444.4 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 1.5 M in 2025.

	2024	2025 (projected)
Short and Long Term Debt Total	4.1M	2.7M
Total Assets	3.5B	3.7B

Short Long Term Debt Total Total Assets

Dermata Therapeutics balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Non Currrent Assets Other
Total Assets		0.43	0.6	-0.03	1.0	-0.95	-0.12	-1.0	0.54	0.15	-0.1	-0.95	1.0	0.97	0.9	0.43	1.0	1.0	-0.11	-0.95	0.41	1.0	-0.01	0.41	-0.56	-0.95
Short Long Term Debt Total	0.43		0.46	0.18	0.44	-0.33	-0.58	-0.44	0.6	0.62	0.33	-0.33	0.43	0.37	0.55	0.84	0.43	0.43	0.6	-0.33	1.0	0.43	0.53	1.0	-0.84	-0.33
Other Current Liab	0.6	0.46		-0.38	0.61	-0.46	-0.68	-0.61	0.82	0.61	0.47	-0.46	0.6	0.5	0.65	0.7	0.6	0.6	0.48	-0.46	0.45	0.6	0.6	0.45	-0.7	-0.46
Total Current Liabilities	-0.03	0.18	-0.38		-0.03	0.07	0.56	0.02	-0.43	-0.45	-0.13	0.07	-0.03	-0.05	-0.05	-0.34	-0.02	-0.02	-0.38	0.07	0.18	-0.03	-0.57	0.18	0.33	0.07
Total Stockholder Equity	1.0	0.44	0.61	-0.03		-0.95	-0.14	-1.0	0.56	0.17	-0.09	-0.95	1.0	0.97	0.91	0.45	1.0	1.0	-0.09	-0.95	0.42	1.0	0.01	0.42	-0.58	-0.95
Current Deferred Revenue	-0.95	-0.33	-0.46	0.07	-0.95		0.12	0.93	-0.44	-0.19	0.1	1.0	-0.95	-0.92	-0.86	-0.37	-0.95	-0.95	0.11	1.0	-0.31	-0.95	0.01	-0.31	0.53	1.0
Net Debt	-0.12	-0.58	-0.68	0.56	-0.14	0.12		0.12	-0.71	-0.98	-0.68	0.12	-0.12	-0.06	-0.3	-0.89	-0.12	-0.12	-0.95	0.12	-0.58	-0.12	-0.99	-0.58	0.83	0.12
Retained Earnings	-1.0	-0.44	-0.61	0.02	-1.0	0.93	0.12		-0.55	-0.14	0.1	0.93	-1.0	-0.97	-0.9	-0.43	-1.0	-1.0	0.11	0.93	-0.42	-1.0	0.01	-0.42	0.56	0.93
Accounts Payable	0.54	0.6	0.82	-0.43	0.56	-0.44	-0.71	-0.55		0.64	0.12	-0.44	0.54	0.39	0.78	0.75	0.54	0.54	0.52	-0.44	0.59	0.54	0.63	0.59	-0.84	-0.44
Cash	0.15	0.62	0.61	-0.45	0.17	-0.19	-0.98	-0.14	0.64		0.72	-0.19	0.15	0.09	0.31	0.89	0.15	0.15	0.95	-0.19	0.62	0.15	0.96	0.62	-0.84	-0.19
Non Current Assets Total	-0.1	0.33	0.47	-0.13	-0.09	0.1	-0.68	0.1	0.12	0.72		0.1	-0.1	-0.09	-0.13	0.55	-0.1	-0.1	0.76	0.1	0.33	-0.1	0.71	0.33	-0.37	0.1
Long Term Debt	-0.95	-0.33	-0.46	0.07	-0.95	1.0	0.12	0.93	-0.44	-0.19	0.1		-0.95	-0.92	-0.86	-0.37	-0.95	-0.95	0.11	1.0	-0.31	-0.95	0.01	-0.31	0.53	1.0
Cash And Short Term Investments	1.0	0.43	0.6	-0.03	1.0	-0.95	-0.12	-1.0	0.54	0.15	-0.1	-0.95		0.97	0.9	0.43	1.0	1.0	-0.11	-0.95	0.41	1.0	-0.01	0.41	-0.56	-0.95
Common Stock Shares Outstanding	0.97	0.37	0.5	-0.05	0.97	-0.92	-0.06	-0.97	0.39	0.09	-0.09	-0.92	0.97		0.77	0.39	0.97	0.97	-0.15	-0.92	0.35	0.97	-0.05	0.35	-0.5	-0.92
Non Current Liabilities Total	0.9	0.55	0.65	-0.05	0.91	-0.86	-0.3	-0.9	0.78	0.31	-0.13	-0.86	0.9	0.77		0.52	0.9	0.9	0.07	-0.86	0.53	0.9	0.16	0.53	-0.7	-0.86
Other Current Assets	0.43	0.84	0.7	-0.34	0.45	-0.37	-0.89	-0.43	0.75	0.89	0.55	-0.37	0.43	0.39	0.52		0.42	0.42	0.83	-0.37	0.84	0.43	0.85	0.84	-0.97	-0.37
Other Stockholder Equity	1.0	0.43	0.6	-0.02	1.0	-0.95	-0.12	-1.0	0.54	0.15	-0.1	-0.95	1.0	0.97	0.9	0.42		1.0	-0.11	-0.95	0.41	1.0	-0.01	0.41	-0.56	-0.95
Total Liab	1.0	0.43	0.6	-0.02	1.0	-0.95	-0.12	-1.0	0.54	0.15	-0.1	-0.95	1.0	0.97	0.9	0.42	1.0		-0.11	-0.95	0.41	1.0	-0.01	0.41	-0.56	-0.95
Net Invested Capital	-0.11	0.6	0.48	-0.38	-0.09	0.11	-0.95	0.11	0.52	0.95	0.76	0.11	-0.11	-0.15	0.07	0.83	-0.11	-0.11		0.11	0.61	-0.11	0.97	0.61	-0.72	0.11
Property Plant And Equipment Gross	-0.95	-0.33	-0.46	0.07	-0.95	1.0	0.12	0.93	-0.44	-0.19	0.1	1.0	-0.95	-0.92	-0.86	-0.37	-0.95	-0.95	0.11		-0.31	-0.95	0.01	-0.31	0.53	1.0
Short Long Term Debt	0.41	1.0	0.45	0.18	0.42	-0.31	-0.58	-0.42	0.59	0.62	0.33	-0.31	0.41	0.35	0.53	0.84	0.41	0.41	0.61	-0.31		0.41	0.54	1.0	-0.83	-0.31
Total Current Assets	1.0	0.43	0.6	-0.03	1.0	-0.95	-0.12	-1.0	0.54	0.15	-0.1	-0.95	1.0	0.97	0.9	0.43	1.0	1.0	-0.11	-0.95	0.41		-0.01	0.41	-0.56	-0.95
Net Working Capital	-0.01	0.53	0.6	-0.57	0.01	0.01	-0.99	0.01	0.63	0.96	0.71	0.01	-0.01	-0.05	0.16	0.85	-0.01	-0.01	0.97	0.01	0.54	-0.01		0.54	-0.76	0.01
Short Term Debt	0.41	1.0	0.45	0.18	0.42	-0.31	-0.58	-0.42	0.59	0.62	0.33	-0.31	0.41	0.35	0.53	0.84	0.41	0.41	0.61	-0.31	1.0	0.41	0.54		-0.83	-0.31
Common Stock	-0.56	-0.84	-0.7	0.33	-0.58	0.53	0.83	0.56	-0.84	-0.84	-0.37	0.53	-0.56	-0.5	-0.7	-0.97	-0.56	-0.56	-0.72	0.53	-0.83	-0.56	-0.76	-0.83		0.53
Non Currrent Assets Other	-0.95	-0.33	-0.46	0.07	-0.95	1.0	0.12	0.93	-0.44	-0.19	0.1	1.0	-0.95	-0.92	-0.86	-0.37	-0.95	-0.95	0.11	1.0	-0.31	-0.95	0.01	-0.31	0.53

Click cells to compare fundamentals

Dermata Therapeutics Account Relationship Matchups

Dermata Therapeutics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	605.5K	11.6M	6.9M	8.0M	3.5B	3.7B
Other Current Liab	133.5K	1.0M	425.9K	757.6K	1.2M	730.3K
Total Current Liabilities	3.8M	1.5M	922.6K	1.6M	2.0M	1.5M
Total Stockholder Equity	(28.1M)	10.1M	6.0M	6.4M	1.6B	1.6B
Net Debt	3.0M	(10.8M)	(6.2M)	(7.4M)	(3.2M)	(3.3M)
Retained Earnings	(28.1M)	(36.0M)	(45.6M)	(53.4M)	(65.7B)	(62.4B)
Accounts Payable	104.3K	515.2K	496.7K	866.0K	808.0K	573.4K
Cash	530.4K	10.8M	6.2M	7.4M	3.2M	5.5M
Cash And Short Term Investments	530.4K	10.8M	6.2M	7.4M	3.2B	3.3B
Liabilities And Stockholders Equity	3.8M	11.6M	6.9M	8.0M	3.5B	3.7B
Non Current Liabilities Total	3.6M	515.2K	496.7K	757.6M	1.2B	1.2B
Other Current Assets	75.1K	825.1K	690.6K	532.1K	612.0K	483.3K
Other Stockholder Equity	81.1M	46.1M	51.6M	59.7M	67.2B	70.6B
Total Liab	3.8M	1.5M	922.6K	1.6M	2.0B	2.1B
Net Invested Capital	367.7K	10.1M	6.0M	6.4M	1.6M	1.5M
Total Current Assets	605.5K	11.6M	6.9M	8.0M	3.2B	3.3B
Net Working Capital	(3.2M)	10.1M	6.0M	6.4M	1.6M	1.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Dermata Stock Analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Dermata Historical Balance Sheet

About Dermata Balance Sheet Analysis

Dermata Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Dermata Therapeutics balance sheet Correlations

Dermata Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dermata Therapeutics balance sheet Accounts

Also Currently Popular

Additional Tools for Dermata Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Short Long Term Debt	+ 1.0	Short Long Term Debt Total

Total Current Assets	- 1.0	Retained Earnings
Total Liab	- 1.0	Retained Earnings
Other Stockholder Equity	- 1.0	Retained Earnings
Cash And Short Term Investments	- 1.0	Retained Earnings
Retained Earnings	- 1.0	Total Stockholder Equity
Retained Earnings	- 1.0	Total Assets